Literature DB >> 17638095

Muscle pain prophylaxis.

G A Dudley1.   

Abstract

Most individuals experience muscle soreness one or two days following novel physical activity such as the first down-hill, snow skiing trip of the season. This arises from forced lengthening of skeletal muscles fibers while they are active, for example, as the skier absorbs the shock of each mogul she/he encounters. Some muscle fibers are injured, force is reduced and an inflammatory response ensues. Muscle proteins are released into the blood, force may further decrease, the injured muscle swells due to edema and soreness increases. These responses reach their peak lowest point within several days of exercise and generally subside within a week. Scientists have developed models which emphasize forced lengthening of skeletal muscle in an effort to study exercise induced muscle injury and the subsequent delayed onset muscle soreness (DOMS) in detail. Several of these studies have examined the efficacy of anti-inflammatory drugs (AIDs) for treatment of the muscle injury and DOMS. The results of some, but not all, of these studies suggest that non-steriodal AIDs (NSAIDs) attenuate muscle injury and perceived soreness while hastening strength recovery. It also appears that NSAIDs attenuate gait disturbances in older individuals evoked by novel, lengthening muscle actions. Future studies need to assess the effect of novel physical activity upon functional capacity as influenced by NSAIDs in older and/or inactive individuals who seem especially vulnerable to contraction induced muscle fiber injury.

Entities:  

Year:  1999        PMID: 17638095     DOI: 10.1007/s10787-999-0007-y

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   5.093


  10 in total

1.  Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage.

Authors:  A E Donnelly; R J Maughan; P H Whiting
Journal:  Br J Sports Med       Date:  1990-09       Impact factor: 13.800

2.  Effect of ibuprofen use on muscle soreness, damage, and performance: a preliminary investigation.

Authors:  S M Hasson; J C Daniels; J G Divine; B R Niebuhr; S Richmond; P G Stein; J H Williams
Journal:  Med Sci Sports Exerc       Date:  1993-01       Impact factor: 5.411

3.  Magnetic resonance imaging and magnetization transfer in experimental myonecrosis in the rat.

Authors:  K T Mattila; R Lukka; T Hurme; M Komu; A Alanen; H Kalimo
Journal:  Magn Reson Med       Date:  1995-02       Impact factor: 4.668

4.  Vulnerability to dysfunction and muscle injury after unloading.

Authors:  L L Ploutz-Snyder; P A Tesch; B M Hather; G A Dudley
Journal:  Arch Phys Med Rehabil       Date:  1996-08       Impact factor: 3.966

5.  Increased vulnerability to eccentric exercise-induced dysfunction and muscle injury after concentric training.

Authors:  L L Ploutz-Snyder; P A Tesch; G A Dudley
Journal:  Arch Phys Med Rehabil       Date:  1998-01       Impact factor: 3.966

6.  Efficacy of naproxen sodium for exercise-induced dysfunction muscle injury and soreness.

Authors:  G A Dudley; J Czerkawski; A Meinrod; G Gillis; A Baldwin; M Scarpone
Journal:  Clin J Sport Med       Date:  1997-01       Impact factor: 3.638

Review 7.  The metabolic effects of exercise-induced muscle damage.

Authors:  W J Evans; J G Cannon
Journal:  Exerc Sport Sci Rev       Date:  1991       Impact factor: 6.230

8.  Strength after bouts of eccentric or concentric actions.

Authors:  C L Golden; G A Dudley
Journal:  Med Sci Sports Exerc       Date:  1992-08       Impact factor: 5.411

9.  Muscle damage is not a function of muscle force but active muscle strain.

Authors:  R L Lieber; J Fridén
Journal:  J Appl Physiol (1985)       Date:  1993-02

10.  Plasma creatine kinase activity and exercise-induced muscle damage in older men.

Authors:  T G Manfredi; R A Fielding; K P O'Reilly; C N Meredith; H Y Lee; W J Evans
Journal:  Med Sci Sports Exerc       Date:  1991-09       Impact factor: 5.411

  10 in total
  1 in total

1.  Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial.

Authors:  Franchek Drobnic; Joan Riera; Giovanni Appendino; Stefano Togni; Federico Franceschi; Xavier Valle; Antoni Pons; Josep Tur
Journal:  J Int Soc Sports Nutr       Date:  2014-06-18       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.